TY - JOUR
T1 - Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults
T2 - Meta-analysis of Individual participant data from prospective cohort studies of the CHANCES consortium
AU - CHANCES consortium
AU - Mons, Ute
AU - Müezzinler, Aysel
AU - Gellert, Carolin
AU - Schöttker, Ben
AU - Abnet, Christian C.
AU - Bobak, Martin
AU - De Groot, Lisette
AU - Freedman, Neal D.
AU - Jansen, Eugène
AU - Kee, Frank
AU - Kromhout, Daan
AU - Kuulasmaa, Kari
AU - Tiina, Laatikainen
AU - O'Doherty, Mark G.
AU - Bas, Bueno De Mesquita
AU - Orfanos, Philippos
AU - Peters, Annette
AU - Van Der Schouw, Yvonne T.
AU - Wilsgaard, Tom
AU - Wolk, Alicja
AU - Trichopoulou, Antonia
AU - Boffetta, Paolo
AU - Brenner, Hermann
AU - Baceviciene, Migle
AU - Boer, Jolanda M.A.
AU - Drygas, Wojciech
AU - Eriksson, Sture
AU - Feskens, Edith
AU - Gafarov, Valeriy
AU - Gardiner, Julian
AU - Håkansson, Niclas
AU - Jansson, Jan Håkan
AU - Jousilahti, Pekka
AU - Kampman, Ellen
AU - Kontto, Jukka
AU - Kubinova, Ruzena
AU - Leenders, Max
AU - Linneberg, Allan
AU - Løchen, Maja Lisa
AU - Lorbeer, Roberto
AU - Malyutina, Sofia
AU - Mathiesen, Ellisiv B.
AU - Melhus, Håkan
AU - Michaëlsson, Karl
AU - Njølstad, Inger
AU - Orsini, Nicola
AU - Pająk, Andrzej
AU - Pikhart, Hynek
AU - Pisinger, Charlotta
AU - Salomaa, Veikko
N1 - Publisher Copyright: © 2015 BMJ Publishing Group Ltd.
PY - 2015/4/20
Y1 - 2015/4/20
N2 - OBJECTIVE: To investigate the impact of smoking and smoking cessation on cardiovascular mortality, acute coronary events, and stroke events in people aged 60 and older, and to calculate and report risk advancement periods for cardiovascular mortality in addition to traditional epidemiological relative risk measures. DESIGN: Individual participant meta-analysis using data from 25 cohorts participating in the CHANCES consortium. Data were harmonised, analysed separately employing Cox proportional hazard regression models, and combined by meta-analysis. RESULTS: Overall, 503 905 participants aged 60 and older were included in this study, of whom 37 952 died from cardiovascular disease. Random effects meta-analysis of the association of smoking status with cardiovascular mortality yielded a summary hazard ratio of 2.07 (95% CI 1.82 to 2.36) for current smokers and 1.37 (1.25 to 1.49) for former smokers compared with never smokers. Corresponding summary estimates for risk advancement periods were 5.50 years (4.25 to 6.75) for current smokers and 2.16 years (1.38 to 2.39) for former smokers. The excess risk in smokers increased with cigarette consumption in a dose-response manner, and decreased continuously with time since smoking cessation in former smokers. Relative risk estimates for acute coronary events and for stroke events were somewhat lower than for cardiovascular mortality, but patterns were similar. CONCLUSIONS: Our study corroborates and expands evidence from previous studies in showing that smoking is a strong independent risk factor of cardiovascular events and mortality even at older age, advancing cardiovascular mortality by more than five years, and demonstrating that smoking cessation in these age groups is still beneficial in reducing the excess risk.
AB - OBJECTIVE: To investigate the impact of smoking and smoking cessation on cardiovascular mortality, acute coronary events, and stroke events in people aged 60 and older, and to calculate and report risk advancement periods for cardiovascular mortality in addition to traditional epidemiological relative risk measures. DESIGN: Individual participant meta-analysis using data from 25 cohorts participating in the CHANCES consortium. Data were harmonised, analysed separately employing Cox proportional hazard regression models, and combined by meta-analysis. RESULTS: Overall, 503 905 participants aged 60 and older were included in this study, of whom 37 952 died from cardiovascular disease. Random effects meta-analysis of the association of smoking status with cardiovascular mortality yielded a summary hazard ratio of 2.07 (95% CI 1.82 to 2.36) for current smokers and 1.37 (1.25 to 1.49) for former smokers compared with never smokers. Corresponding summary estimates for risk advancement periods were 5.50 years (4.25 to 6.75) for current smokers and 2.16 years (1.38 to 2.39) for former smokers. The excess risk in smokers increased with cigarette consumption in a dose-response manner, and decreased continuously with time since smoking cessation in former smokers. Relative risk estimates for acute coronary events and for stroke events were somewhat lower than for cardiovascular mortality, but patterns were similar. CONCLUSIONS: Our study corroborates and expands evidence from previous studies in showing that smoking is a strong independent risk factor of cardiovascular events and mortality even at older age, advancing cardiovascular mortality by more than five years, and demonstrating that smoking cessation in these age groups is still beneficial in reducing the excess risk.
UR - https://www.scopus.com/pages/publications/84929497683
U2 - 10.1136/bmj.h1551
DO - 10.1136/bmj.h1551
M3 - Article
C2 - 25896935
SN - 1756-1833
VL - 350
JO - BMJ (Clinical research ed.)
JF - BMJ (Clinical research ed.)
M1 - h1551
ER -